瑞士 - 德文 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - deferoxamini mesilas - injektionspräparat - vorbereitung cryodesiccata: deferoxamini mesilas 500 mg für glas. - chronische eisenüberladung,akute eisenvergiftung, chronische aluminiumüberladung bei dialyse-patienten - synthetika

以色列 - 英文 - Ministry of Health

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

以色列 - 英文 - Ministry of Health

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

以色列 - 英文 - Ministry of Health

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

瑞士 - 法文 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - deferoxamini mesilas - injektionspräparat - préparation cryodesiccata: deferoxamini mesilas 500 mg pour le verre. - la surcharge en fer chronique,aiguë eisenvergiftung, chronique aluminiumüberladung en cas de dialyse des patients - synthetika

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - deferoxamine mesilate - pdr/conc/soln/inj/inf - 500 milligram - iron chelating agents

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

novartis ireland limited - deferoxamine mesilate - powder for solution for injection/infusion - 500 milligram(s) - iron chelating agents; deferoxamine

法国 - 法文 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

novartis pharma sas - mésilate de déféroxamine - poudre - 2 g - composition pour un flacon > mésilate de déféroxamine : 2 g solvant composition > pas de substance active. : - divers/antidotes/agents chÉlateurs du fer

比利时 - 法文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - mésilate de déferoxamine 500 mg - poudre pour solution injectable - 500 mg - mésilate de déferoxamine 500 mg - deferoxamine

马耳他 - 英文 - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - deferoxamine - powder for solution for injection - deferoxamine 500 mg - all other therapeutic products